| |
 |
|
|
|
|
|
Poster: 183
Visits: 93
Title: Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B-CLL cells and FCGR3A polymorphism. A study of FCGCLL/MW and GOELAMS groups.
Authors: Anne-laure Gagez , E Tuaillon, R Cezar, C Cartigeas, B Mahé, R Letestu, H Maisonneuve, V Gouilleux-Gruat, K Bollore, E Ferrant, T Aurran,P Feugier, S Leprtre, G Cartron
Centre: CNRS UMR-5235, INSERM U1058
|
|
You must be registered to reply or comment.
|
|
RESPONSE TO RITUXIMAB IN B-CLL PATIENTS IS ADVERSELY IMPACTED BY FREQUENCY OF IL-10 COMPETENT B-CLL CELLS AND FCGR3A POLYMORPHISM. A STUDY OF FCGCLL/MW AND GOELAMS GROUPS.
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 169
Visits: 178
Title: Chronic Lymphocytic Leukemia B-cells are rescued from apoptosis by extracellular vesicles from bone marrow mesenchymal stromal cells
Authors: Emerence Crompot ,
Centre: LTCC
|
|
|
|
